These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 30796560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
    Hitt R, Iglesias L, López-Pousa A, Berrocal-Jaime A, Grau JJ, García-Girón C, Martínez-Trufero J, Guix M, Lambea-Sorrosal J, Del Barco-Morillo E, León-Vintró X, Cunquero-Tomas AJ, Baste N, Ocaña A, Cruz-Hernández JJ, the Spanish Head and Neck Cancer Cooperative Group (TTCC).
    Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376
    [Abstract] [Full Text] [Related]

  • 4. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM, Bernstein JM, Mais K, Garcez K, Lee LW, Sykes A, Thomson DJ, Homer JJ, West CM, Slevin NJ.
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
    [Abstract] [Full Text] [Related]

  • 5. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
    Driessen CM, de Boer JP, Gelderblom H, Rasch CR, de Jong MA, Verbist BM, Melchers WJ, Tesselaar ME, van der Graaf WT, Kaanders JH, van Herpen CM.
    Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
    Nakahara S, Takenaka Y, Ogawa K, Nishiike S, Yamamoto Y, Seo Y, Isohashi F, Suzuki O, Yoshioka Y, Sumida I, Yoshii T, Tomiyama Y, Inohara H.
    Int J Clin Oncol; 2016 Dec; 21(6):1030-1037. PubMed ID: 27306220
    [Abstract] [Full Text] [Related]

  • 7. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
    Kim R, Hahn S, Shin J, Ock CY, Kim M, Keam B, Kim TM, Kim DW, Heo DS.
    Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
    [Abstract] [Full Text] [Related]

  • 8. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
    Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, Marchand P, Braegas B, Seiwert TY, Villaflor VM, Haraf DJ, Vokes EE.
    J Clin Oncol; 2014 Sep 01; 32(25):2735-43. PubMed ID: 25049329
    [Abstract] [Full Text] [Related]

  • 9. Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study.
    Hsieh CY, Lein MY, Yang SN, Wang YC, Lin YJ, Lin CY, Hua CH, Tsai MH, Lin CC.
    BMC Cancer; 2020 Sep 01; 20(1):832. PubMed ID: 32873270
    [Abstract] [Full Text] [Related]

  • 10. A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.
    Mesía R, Vázquez S, Grau JJ, García-Sáenz JA, Lozano A, García C, Carles J, Irigoyen A, Mañós M, García-Paredes B, del Barco E, Taberna M, Escobar Y, Cruz JJ, Spanish Head and Neck Cancer Cooperative Group (TTCC).
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):289-96. PubMed ID: 26675064
    [Abstract] [Full Text] [Related]

  • 11. Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial.
    Keil F, Hartl M, Altorjai G, Berghold A, Riedl R, Pecherstorfer M, Mayrbäurl B, De Vries A, Schuster J, Hackl J, Füreder T, Melchardt T, Burian M, Greil R.
    Eur J Cancer; 2021 Jul 01; 151():201-210. PubMed ID: 34022697
    [Abstract] [Full Text] [Related]

  • 12. A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
    Keam B, Lee KW, Lee SH, Kim JS, Kim JH, Wu HG, Eom KY, Kim S, Ahn SH, Chung EJ, Kwon SK, Jeong WJ, Jung YH, Kim JW, Heo DS.
    Oncologist; 2019 Jun 01; 24(6):751-e231. PubMed ID: 30796155
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, Pallini A, Nascimben O, Biason R, Oniga F, Medici M, Rossi F, Fila G.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):481-7. PubMed ID: 15145166
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.
    Izawa N, Onozawa Y, Hikosaka T, Hamauchi S, Tsushima T, Todaka A, Machida N, Haraguchi Y, Ogawa H, Nishimura T, Nakagawa M, Fuke T, Iida Y, Kamijo T, Onitsuka T, Boku N, Yasui H, Yokota T.
    Int J Clin Oncol; 2015 Jun 01; 20(3):455-62. PubMed ID: 25248339
    [Abstract] [Full Text] [Related]

  • 15. Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.
    Balermpas P, Bauer C, Fraunholz I, Ottinger A, Wagenblast J, Stöver T, Seitz O, Fokas E, Rödel C, Weiss C.
    Strahlenther Onkol; 2014 Mar 01; 190(3):256-62. PubMed ID: 24413895
    [Abstract] [Full Text] [Related]

  • 16. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M.
    Clin Oncol (R Coll Radiol); 2005 May 01; 17(3):148-52. PubMed ID: 15900997
    [Abstract] [Full Text] [Related]

  • 17. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H, Tahara M, Mochizuki S, Kato K, Hara H, Yokota T, Kiyota N, Kii T, Chin K, Zenda S, Kojima T, Bando H, Yamazaki T, Iwasa S, Honma Y, Hamauchi S, Tsushima T, Ohtsu A.
    Cancer Chemother Pharmacol; 2016 Jul 01; 78(1):91-9. PubMed ID: 27193097
    [Abstract] [Full Text] [Related]

  • 18. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e237-43. PubMed ID: 21620580
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M, Karakaya E, Young CA, Dyker KE, Coyle C, Sen M, Prestwich RJ.
    Clin Oncol (R Coll Radiol); 2013 Nov 15; 25(11):647-53. PubMed ID: 23948462
    [Abstract] [Full Text] [Related]

  • 20. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.
    Oral Oncol; 2006 Aug 15; 42(7):675-84. PubMed ID: 16731029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.